1st Quarter - Report

AMERICAN CANCER SOCIETY, CALIFORNIA DIVISION, INC. for AMERICAN CANCER SOCIETY CALIFORNIA DIVISION INC

Firm
Client
Income
—
Expenses
$360,000
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Tobacco TOB

Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, product regulation, and smokefree environments, including: (1) implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31): (2) cessation and prevention programs authorized as part of P.L. 111-148, the Patient Protection & Affordable Care Act of 2010; (3) legislation regarding Congressional review/approval of regulations, including H.R. 10, the Regulations from the Executive in Need of Security Act of 2011; (4) Framework Convention on Tobacco Control (FCTC); and (5) issues relating to NIH reorganization. Legislation includes H.R. 3186 and S. 1706, Smuggled Tobacco Prevention Act; H.R. 3382, Smoke-Free Federal Building Act; S. 1403, IDEA Full Funding Act; And H.R. 65: Candy Tobacco Tax Parity Act of 2011.

LobbyistCovered position, as disclosed
KEVIN KEANE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3186 (112th), S. 1403 (112th), H.R. 3382 (112th), H.R. 65 (112th), H.R. 10 (112th), S. 1706 (112th)

Health Issues HCR

Issues relating to health disparities, health care reform, quality of life, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation: S. 494 and H.R. 912, Colorectal Cancer Prevention, Early Detection & treatment Act; H.R. 1213, Repeal mandatory funding provided to states in PPACA to establish American Health Benefit Exchanges; H.R. 1217, Repeal Prevention and Public Health Fund; H.R. 1740 and H.R. 5560, the Quality Cancer Care for Life Act of 2010; H.R. 2941 and S. 3493; HR 3974, Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009; HR 4662, the Lymphedema Diagnosis and Treatment Cost Savings Act of 2010; the implementation of P.L. 111-148, the Patient Protection and Affordable Care Act of 2010; S. 1064, the Sun Act; S. 965, the Family Act; HR 2954, Health Equity and Accountability Act of 2011; and HR 2077, the MLR Repeal Act; H.R. 2245 and S. 296 Preserving Access to Life-Saving Medications Act, issues related to the reauthorization of the prescription drug user fee, and issues relating to the ongoing national shortage of cancer drugs.

LobbyistCovered position, as disclosed
KEVIN KEANE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 912 (112th), H.R. 5560 (112th), H.R. 1213 (112th), S. 494 (112th), H.R. 2245 (112th), H.R. 2954 (112th), H.R. 1740 (112th), S. 3493 (112th), S. 296 (112th), S. 965 (112th), S. 1064 (112th), H.R. 2941 (112th), H.R. 2077 (112th), H.R. 3974 (112th), H.R. 1217 (112th), H.R. 4662 (112th)

Medicare/Medicaid MMM

Issues relating to implementation of changes to Medicare and Medicaid, pursuant to P.L. 111-148, the Patient Protection and Affordable Care Act of 2010, and tobacco cessation programs within Medicaid, including S. 868 and H.R. 1683, the State Flexibility Act (MOE); and matters under consideration by the Joint Select Committee on Deficit Reduction.

LobbyistCovered position, as disclosed
KEVIN KEANE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 868 (112th), H.R. 1683 (112th)

Budget/Appropriations BUD

Federal budget and appropriations for cancer research and programs, including federal appropriations for NIH, NCI, CDC; the Prevention & Public Health Fund; the Affordable Care Act provisions; programs for breast and cervical cancer, colorectal cancer, tobacco regulation and cessation, patient navigators, and international health; and matters under consideration by the Joint Select Committee on Deficit Reduction. Legislation includes H. Con. Res. 34, establishing the budget for the US Government for FY 2012; S. 1599, legislation including draft House text of legislation making appropriations for L-HHS FY 12; H.R. 2055 and S. 3671, Consolidated Appropriations Act of 2012.

LobbyistCovered position, as disclosed
KEVIN KEANE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 3671 (112th), H.R. 2055 (112th), S. 1599 (112th), H.Con.Res. 34 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.